Action of alpha-latrotoxin from black widow spider venom on a cerebral cortex preparation: release of neurotransmitters, depletion of synaptic vesicles, and binding to membrane.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001180:Arthropod Venoms / Q000494:pharmacology*; D001665:Binding Sites; D001740:Black Widow Spider; D002462:Cell Membrane / Q000378:metabolism; D002540:Cerebral Cortex / Q000502:physiology*; D004533:Egtazic Acid / Q000494:pharmacology; D051379:Mice; D018377:Neurotransmitter Agents / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D011506:Proteins / Q000494:pharmacology*; D051381:Rats; D013111:Spider Venoms / Q000494:pharmacology*; D013112:Spiders; D013572:Synaptic Vesicles / Q000378:metabolism*; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D001180:Arthropod Venoms; D018377:Neurotransmitter Agents; D011506:Proteins; D013111:Spider Venoms; D004533:Egtazic Acid; D005680:gamma-Aminobutyric Acid; C020763:alpha-latrotoxin; D000109:Acetylcholine; D009638:Norepinephrine